{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:13:48Z","timestamp":1788459228641,"version":"build-2803163510"},"reference-count":149,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lodz","award":["503\/1-152-01\/503-11-002"],"award-info":[{"award-number":["503\/1-152-01\/503-11-002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Skin paraneoplastic syndromes (SPNSs) are a group of disorders that arise as a consequence of cancer but are not directly related to the tumor mass itself. This review aims to provide a comprehensive overview of these syndromes, encompassing their pathophysiology, clinical features, diagnostic approaches, differential diagnosis, and management strategies. These syndromes, which include conditions such as Bazex syndrome, acanthosis nigricans, dermatomyositis, and necrolytic migratory erythema often manifest prior to or concurrently with a cancer diagnosis, serving as potential early warning signs of underlying malignancies. This review delves into the spectrum of SPNSs and their associations with specific cancer types. Special emphasis is placed on the critical role of dermatologists and oncologists in identifying these skin manifestations as potential markers of malignancy. By raising awareness of SPNSs, this paper highlights the pivotal importance of prompt recognition and intervention in reducing cancer-related mortality.<\/jats:p>","DOI":"10.3390\/cancers17071053","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T04:58:38Z","timestamp":1742533118000},"page":"1053","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Importance and Challenges of Early Diagnosis of Paraneoplastic Skin Syndromes in Cancer Detection\u2014A Review"],"prefix":"10.3390","volume":"17","author":[{"given":"Aleksandra","family":"Ro\u015bciszewska","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Tokarska","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Ko\u015bny","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4246-5049","authenticated-orcid":false,"given":"Paulina","family":"Karp","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Leja","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-3080","authenticated-orcid":false,"given":"Agnieszka","family":"\u017bebrowska","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"ref_1","first-page":"456","article-title":"Cutaneous manifestations of internal malignancy","volume":"18","author":"Alter","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962013000100001","article-title":"Paraneoplastic cutaneous manifestations: Concepts and updates","volume":"88","author":"Silva","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00000441-200105000-00002","article-title":"Erythema gyratum repens","volume":"321","author":"Eubanks","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1468-3083.2012.04663.x","article-title":"Erythema gyratum repens is not an obligate paraneoplastic disease: A systematic review of the literature and personal experience","volume":"28","author":"Rongioletti","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0190-9622(92)70107-Q","article-title":"Erythema gyratum repens: A paraneoplastic eruption","volume":"26","author":"Boyd","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2133.1977.tb07127.x","article-title":"Erythema gyratum repens\u2014An immunologically mediated dermatosis?","volume":"96","author":"Holt","year":"1977","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2133.1994.tb08465.x","article-title":"Erythema gyratum repens. A case studied with immunofluorescence, immunoelectron microscopy and immunohistochemistry","volume":"131","author":"Caux","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clindermatol.2004.06.011","article-title":"Life-threatening paraneoplastic cutaneous syndromes","volume":"23","author":"Stone","year":"2005","journal-title":"Clin. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200607020-00001","article-title":"Cutaneous manifestations of internal malignancy","volume":"7","author":"Kleyn","year":"2006","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-4362.1995.tb04391.x","article-title":"Genetic and acquired cutaneous disorders associated with internal malignancy","volume":"34","author":"Loucas","year":"1995","journal-title":"Int. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0190-9622(08)80862-6","article-title":"Erythema gyratum repens without underlying disease","volume":"28","author":"Boyd","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-4362.2000.00996.x","article-title":"Erythema gyratum repens-like psoriasis","volume":"39","author":"Jablonska","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5114\/dr.2017.69769","article-title":"Bullous pemphigoid resembling erythema gyratum repens\u2014Case report","volume":"104","author":"Dominiak","year":"2017","journal-title":"Dermatol. Rev.\/Przegl\u0105d Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archderm.1975.01630140085011","article-title":"Erythema gyratum repens with metastatic adenocarcinoma","volume":"111","author":"Skolnick","year":"1975","journal-title":"Arch. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lungcan.2020.07.030","article-title":"Necrolytic migratory erythema-like eruption associated with erlotinib in a patient with lung adenocarcinoma","volume":"148","author":"Ma","year":"2020","journal-title":"Lung Cancer"},{"key":"ref_16","first-page":"22","article-title":"Necrolytic migratory erythema (glucagenoma)-like skin lesions induced by EGF-receptor inhibition","volume":"133","author":"Trojan","year":"2003","journal-title":"Swiss Med. Wkly."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamadermatol.2016.1098","article-title":"Necrolytic Migratory Erythema\u2013like Skin Lesion During Gefitinib Treatment: A Rare Cutaneous Adverse Reaction","volume":"152","author":"Seong","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/1203475417719051","article-title":"Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition","volume":"21","author":"Tremblay","year":"2017","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_19","unstructured":"Vinik, A., Feliberti, E., and Perry, R. (2025, January 15). Glucagonoma Syndrome, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279041\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.semdp.2019.01.001","article-title":"Cutaneous paraneoplastic syndromes","volume":"36","author":"Wick","year":"2019","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_21","unstructured":"Foss, M.G., Hashmi, M.F., and Ferrer-Bruker, S.J. (2023). Necrolytic Migratory Erythema. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.0303-6987.2006.00408.x","article-title":"Necrolytic migratory erythema","volume":"33","author":"Korom","year":"2006","journal-title":"J. Cutan. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0748-7983(98)93716-7","article-title":"Necrolytic migratory erythema, first symptom of a malignant glucagonoma: Treatment by long-acting somatostatin and surgical resection. Report of three cases","volume":"24","author":"Partensky","year":"1998","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/ijd.13947","article-title":"A review of cutaneous manifestations within glucagonoma syndrome: Necrolytic migratory erythema","volume":"57","author":"Tolliver","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_25","first-page":"1484089","article-title":"Glucagonoma and Glucagonoma Syndrome: A Case Report with Review of Recent Advances in Management","volume":"2016","author":"Ajarma","year":"2016","journal-title":"Case Rep. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0190-9622(93)70022-L","article-title":"Cutaneous markers of internal malignancy, I.I. Paraneoplastic dermatoses and environmental carcinogens","volume":"28","author":"Poole","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s004050050044","article-title":"Bazex syndrome (acrokeratosis paraneoplastica)","volume":"255","author":"Sarkar","year":"1998","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000513828","article-title":"A Review of Nail Changes in Acrokeratosis Paraneoplastica (Bazex Syndrome)","volume":"7","author":"Roy","year":"2021","journal-title":"Skin. Appendage Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jdv.14199","article-title":"Acrokeratosis paraneoplastica (Bazex syndrome)\u2014A systematic review on risk factors, diagnosis, prognosis and management","volume":"31","author":"Goetze","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000452827","article-title":"Bazex Syndrome in Lung Squamous Cell Carcinoma: High Expression of Epidermal Growth Factor Receptor in Lesional Keratinocytes with Th2 Immune Shift","volume":"8","author":"Amano","year":"2016","journal-title":"Case Rep. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1468-3083.2005.01083.x","article-title":"Acrokeratosis paraneoplastica: Bazex syndrome","volume":"19","author":"Valdivielso","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_34","first-page":"e45368","article-title":"Bazex Syndrome (Acrokeratosis Paraneoplastica): A Narrative Review of Pathogenesis, Clinical Manifestations, and Therapeutic Approaches","volume":"15","author":"Shah","year":"2023","journal-title":"Cureus"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2340\/00015555-3085","article-title":"Acrokeratosis Paraneoplastica-like Findings as a Manifestation of Systemic Lupus Erythematosus","volume":"99","author":"Huilaja","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0738-081X(93)90079-R","article-title":"Bazex\u2019 syndrome","volume":"11","author":"Bolognia","year":"1993","journal-title":"Clin. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13030\/qt8n96v45x","DOI":"10.5070\/D3229032512","article-title":"Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx","volume":"22","author":"Vaynshtok","year":"2016","journal-title":"Dermatol. Online J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","article-title":"An acute febrile neutrophilic dermatosis","volume":"76","author":"Sweet","year":"1964","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.amjmed.2010.02.017","article-title":"Sweet\u2019s syndrome","volume":"123","author":"Fazili","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_40","first-page":"8","article-title":"Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis)","volume":"5","author":"Burrall","year":"1999","journal-title":"Dermatol. Online J."},{"key":"ref_41","first-page":"167","article-title":"Diagnostic criteria for Sweet\u2019s syndrome","volume":"37","author":"Su","year":"1986","journal-title":"Cutis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0190-9622(94)70215-2","article-title":"Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis)","volume":"31","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet Syndrome: A Review and Update","volume":"107","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archderm.1971.04000130083013","article-title":"Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis)","volume":"103","author":"Shapiro","year":"1971","journal-title":"Arch. Dermatol."},{"key":"ref_45","first-page":"160","article-title":"Sweet syndrome and acute myeloid leukemia","volume":"104","author":"Pirard","year":"1977","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ajh.2830320211","article-title":"Chronic myelogenous leukemia and Sweet syndrome","volume":"32","author":"Cohen","year":"1989","journal-title":"Am. J. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1468-3083.2005.01207.x","article-title":"Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis) associated with adenocarcinoma of prostate and transitional cell carcinoma of urinary bladder","volume":"19","author":"Hussein","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_48","unstructured":"Adil, A., Goyal, A., and Quint, J.M. (2023). Behcet Disease. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13223-018-0265-6","article-title":"Sweet syndrome: A rare feature of ANCA-associated vasculitis or unusual consequence of azathioprine-induced treatment","volume":"14","author":"Elsayed","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e12619","DOI":"10.1111\/dth.12619","article-title":"Treatment of Sweet\u2019s syndrome in pregnancy","volume":"31","author":"Corbeddu","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00128071-200203020-00005","article-title":"Sweet\u2019s syndrome: A review of current treatment options","volume":"3","author":"Cohen","year":"2002","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Didona, D., Rallo, A., Carugno, A., and Paolino, G. (2025). Paraneoplastic Dermatoses: A Clue for Underlying Malignancies. J. Clin. Med., 14.","DOI":"10.3390\/jcm14031014"},{"key":"ref_53","first-page":"645","article-title":"Sweet syndrome: An update on clinical aspects, pathophysiology, and treatment","volume":"159","author":"Calabrese","year":"2024","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ijd.14637","article-title":"Paraneoplastic pyoderma gangrenosum in solid organ malignancy: A literature review","volume":"59","author":"Shah","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0738-081X(93)90109-P","article-title":"Pyoderma gangrenosum","volume":"11","author":"Duguid","year":"1993","journal-title":"Clin. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-020-0213-x","article-title":"Pyoderma gangrenosum","volume":"6","author":"Maverakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum\u2014A guide to diagnosis and management","volume":"19","author":"George","year":"2019","journal-title":"Clin. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5021\/ad.2018.30.1.79","article-title":"Paraneoplastic Pyoderma Gangrenosum Associated with Rectal Adenocarcinoma","volume":"30","author":"You","year":"2018","journal-title":"Ann. Dermatol."},{"key":"ref_61","first-page":"625","article-title":"Exfoliative dermatitis","volume":"59","author":"Karakayli","year":"1999","journal-title":"Am. Fam. Physician"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100499","DOI":"10.1016\/j.currproblcancer.2019.100499","article-title":"Erythroderma as a paraneoplastic manifestation of small cell lung cancer","volume":"44","author":"Zervakis","year":"2020","journal-title":"Curr. Probl. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/ijd.14970","article-title":"Paraneoplastic erythroderma: An insight on the existing data","volume":"59","author":"Plachouri","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-4362.1998.00228.x","article-title":"Erythroderma: A clinico-etiologic study of 90 cases","volume":"37","author":"Pal","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0733-8635(05)70189-3","article-title":"Erythroderma","volume":"18","author":"Rothe","year":"2000","journal-title":"Dermatol. Clin."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000249271","article-title":"Exfoliative dermatitis: A prospective study of 80 patients","volume":"173","author":"Sehgal","year":"1986","journal-title":"Dermatologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-4362.1988.tb03219.x","article-title":"S\u00e9zary cell count in exfoliative dermatitis","volume":"27","author":"Duangurai","year":"1988","journal-title":"Int. J. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0738-081X(93)90084-P","article-title":"Erythroderma and exfoliative dermatitis","volume":"11","author":"Wilson","year":"1993","journal-title":"Clin. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-4632.2009.04387.x","article-title":"Primary manifestation of erythema gyratum repens as a transient erythroderma in a patient with bronchial carcinoma","volume":"49","author":"Lorenz","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_70","first-page":"93","article-title":"Erythrodermic psoriasis: Pathophysiology and current treatment perspectives","volume":"6","author":"Singh","year":"2016","journal-title":"Psoriasis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/jdv.14761","article-title":"Pityriasis rubra pilaris: Algorithms for diagnosis and treatment","volume":"32","author":"Roenneberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Roccuzzo, G., Giordano, S., Avallone, G., Rubatto, M., Canonico, S., Funaro, A., Ortolan, E., Senetta, R., Fava, P., and Fierro, M.T. (2022). S\u00e9zary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System. Cells, 11.","DOI":"10.3390\/cells11030333"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/0253-7613.121381","article-title":"Allopurinol induced erythroderma","volume":"45","author":"Sharma","year":"2013","journal-title":"Indian J. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2133.1989.tb01436.x","article-title":"Exfoliative dermatitis due to nifedipine","volume":"121","author":"Reynolds","year":"1989","journal-title":"Br. J. Dermatol."},{"key":"ref_76","first-page":"582","article-title":"Cefoxitin-associated exfoliative dermatitis","volume":"2","author":"Tietze","year":"1983","journal-title":"Clin. Pharm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.ASW.0000463573.40637.73","article-title":"A Review of the Diagnosis and Management of Erythroderma (Generalized Red Skin)","volume":"28","author":"Mistry","year":"2015","journal-title":"Adv. Skin. Wound Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J. Autoimmun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08361.x","article-title":"Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus","volume":"158","author":"Liu","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1368-8375(98)00059-1","article-title":"Paraneoplastic pemphigus: A review","volume":"34","author":"Sklavounou","year":"1998","journal-title":"Oral. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-4362.2001.01169.x","article-title":"Paraneoplastic pemphigus","volume":"40","author":"Jih","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.coms.2008.06.008","article-title":"Pemphigus Vulgaris and Paraneoplastic Pemphigus","volume":"20","author":"Edgin","year":"2008","journal-title":"Oral. Maxillofac. Surg. Clin. N. Am."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Paolino, G., Didona, D., Magliulo, G., Iannella, G., Didona, B., Mercuri, S.R., Moliterni, E., Donati, M., Ciofalo, A., and Granata, G. (2017). Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122532"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-9394(14)74494-0","article-title":"Conjunctival involvement in paraneoplastic pemphigus","volume":"114","author":"Meyers","year":"1992","journal-title":"Am. J. Ophthalmol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_87","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1590\/abd1806-4841.20199165","article-title":"Paraneoplastic pemphigus: A clinical, laboratorial, and therapeutic overview","volume":"94","author":"Maruta","year":"2019","journal-title":"An. Bras. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40257-016-0235-z","article-title":"Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment","volume":"18","author":"Kartan","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Didona, D., Fania, L., Didona, B., Eming, R., Hertl, M., and Di Zenzo, G. (2020). Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062178"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-0960.2012.00921.x","article-title":"Paraneoplastic pemphigus","volume":"54","author":"Yong","year":"2013","journal-title":"Australas. J. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2012.01655.x","article-title":"Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus","volume":"39","author":"Choi","year":"2012","journal-title":"J. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12969-023-00871-2","article-title":"Systemic lupus erythematosus combined with Castleman disease and secondary paraneoplastic pemphigus: A case report","volume":"21","author":"Ma","year":"2023","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000018182","article-title":"Paraneoplastic pemphigus: A case of long-term survival associated with systemic lupus erythematosus and polymyositis","volume":"199","author":"Mascaro","year":"1999","journal-title":"Dermatology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archderm.136.5.652","article-title":"Lichenoid dermatitis in paraneoplastic pemphigus: A pathogenic trigger of epitope spreading?","volume":"136","author":"Bowen","year":"2000","journal-title":"Arch Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.2005.126_1.x","article-title":"Paraneoplastic pemphigus: A brief update","volume":"46","author":"Wade","year":"2005","journal-title":"Australas. J. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaad.2018.02.021","article-title":"Diagnosis and management of pemphigus: Recommendations of an international panel of experts","volume":"82","author":"Murrell","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00277-017-3008-8","article-title":"Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus","volume":"96","author":"Kikuchi","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjd.12324","article-title":"Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus","volume":"169","author":"Bech","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2004.00280.x","article-title":"Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia","volume":"73","author":"Hohwy","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2007.00322.x","article-title":"Paraneoplastic pemphigus","volume":"34","author":"Zhu","year":"2007","journal-title":"J. Dermatol."},{"key":"ref_105","first-page":"492","article-title":"Clinical Analysis of Unicentric Castleman\u2019s Disease with Paraneoplastic Pemphigus and Bronchiolitis Obliterans","volume":"39","author":"Zhen","year":"2017","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/1744666X.2023.2270737","article-title":"A comprehensive review of dermatomyositis treatments\u2014From rediscovered classics to promising horizons","volume":"20","author":"Sevim","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/acr.24786","article-title":"Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-Based Cohort Study","volume":"75","author":"Kronzer","year":"2023","journal-title":"Arthritis Care Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/art.22205","article-title":"HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies","volume":"54","author":"Rider","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Gao, X., Han, L., Yuan, L., Yang, Y., Gou, G., Sun, H., Lu, L., and Bao, L. (2014). HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population. BMC Dermatol., 14.","DOI":"10.1186\/1471-5945-14-9"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.12688\/f1000research.20646.1","article-title":"Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies","volume":"8","author":"Okiyama","year":"2019","journal-title":"F1000Research"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/09546634.2012.697540","article-title":"Review of dermatomyositis: Establishing the diagnosis and treatment algorithm","volume":"24","author":"Strowd","year":"2013","journal-title":"J. Dermatolog Treat."},{"key":"ref_112","unstructured":"Pappu, R., and Seetharaman, M. (2011, June 08). Polymoysitis. In Medscape Reference. Available online: http:\/\/emedicine.medscape.com\/article\/335925."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiographics.15.3.7624563","article-title":"The idiopathic inflammatory myopathies: Spectrum of MR imaging findings","volume":"15","author":"Adams","year":"1995","journal-title":"Radiographics"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13317-014-0062-2","article-title":"Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis","volume":"5","author":"Vattemi","year":"2014","journal-title":"Auto. Immun. Highlights"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: A quantitative study","volume":"27","author":"Engel","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-0172(98)80052-8","article-title":"High incidence of malignancies in patients with dermatomyositis and polymyositis: An 11-year analysis","volume":"27","author":"Maoz","year":"1998","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Sato, Y., Tanino, Y., Nikaido, T., Togawa, R., Kawamata, T., Watanabe, N., Sato, R., Yamada, R., Onuma, T., and Tomita, H. (2022). Development of dermatomyositis after anti-transcriptional intermediary factor 1-\u03b3 antibody seroconversion during treatment for small cell lung cancer. BMC Pulm. Med., 22.","DOI":"10.1186\/s12890-022-01974-4"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/art.33402","article-title":"Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection","volume":"64","author":"Fiorentino","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Harada, Y., Tominaga, M., Iitoh, E., Kaieda, S., Koga, T., Fujimoto, K., Chikasue, T., Obara, H., Kakuma, T., and Ida, H. (2022). Clinical Characteristics of Anti-TIF-1\u03b3 Antibody-Positive Dermatomyositis Associated with Malignancy. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071925"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"251","DOI":"10.14740\/gr841w","article-title":"Paraneoplastic Dermatomyositis Syndrome Presenting as Dysphagia","volume":"10","author":"Ofori","year":"2017","journal-title":"Gastroenterology Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archderm.1980.01640270055013","article-title":"The relationship of dermatomyositis and polymyositis to internal malignancy","volume":"116","author":"Callen","year":"1980","journal-title":"Arch. Dermatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5021\/ad.24.022","article-title":"Updates in Dermatomyositis: Newer Treatment Options and Outcome Measures From Dermatologic Perspectives","volume":"36","author":"Kim","year":"2024","journal-title":"Ann. Dermatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e21733","DOI":"10.1097\/MD.0000000000021733","article-title":"Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China","volume":"99","author":"Chang","year":"2020","journal-title":"Medicine"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-8722-3-2","article-title":"Leser-Tr\u00e9lat syndrome in patients affected by six multiple metachronous primitive cancers","volume":"3","author":"Ponti","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000327363","article-title":"Leser-Tr\u00e9lat Sign without Internal Malignancy","volume":"4","author":"Safa","year":"2011","journal-title":"Case Rep. Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1610-0387.2008.06788.x","article-title":"Seborrheic keratosis","volume":"6","author":"Hafner","year":"2008","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2133.2003.05463.x","article-title":"Eruptive seborrhoeic keratosis in human immunodeficiency virus infection: A coincidence or \u2018the sign of Leser-Tr\u00e9lat\u2019?","volume":"149","author":"Inamadar","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ajd.13781","article-title":"Dermoscopy of inflamed seborrheic keratosis: A great mimic of malignancy","volume":"63","author":"Serrano","year":"2022","journal-title":"Australas. J. Dermatol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.36740\/WLek202201204","article-title":"Seborrheic keratosis: current state of the problem","volume":"75","author":"Myroshnychenko","year":"2022","journal-title":"Wiad. Lek."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5021\/ad.2016.28.2.152","article-title":"Clinical and Histopathological Investigation of Seborrheic Keratosis","volume":"28","author":"Roh","year":"2016","journal-title":"Ann. Dermatol."},{"key":"ref_132","first-page":"825929","article-title":"Sign of leser-tr\u00e9lat associated with esophageal squamous cell cancer","volume":"2014","author":"Gaduputi","year":"2014","journal-title":"Case Rep. Oncol. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"103065","DOI":"10.1016\/j.amsu.2021.103065","article-title":"Leser-Trelat sign preceding male breast cancer","volume":"72","author":"Aouali","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"ref_134","first-page":"202","article-title":"Leser-Tr\u00e9lat Sign as a Marker for Underlying Pancreatic Cancer","volume":"7","author":"Modi","year":"2023","journal-title":"Clin. Pract. Cases Emerg. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdcr.2023.04.022","article-title":"Leser-Trelat sign: Eruptive seborrheic keratoses and primary lung adenocarcinomas with an epidermal growth factor receptor mutation","volume":"37","author":"Mathien","year":"2023","journal-title":"JAAD Case Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.12688\/f1000research.18983.1","article-title":"Recent advances in managing and understanding seborrheic keratosis","volume":"8","author":"Wollina","year":"2019","journal-title":"F1000Research"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamadermatol.2019.1127","article-title":"Acanthosis Nigricans Maligna","volume":"155","author":"Prokop","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Zhang, X., Liu, R., Liu, Y., Zhang, S., and Qi, H. (2020). Malignant acanthosis nigricans: A case report. BMC Ophthalmol., 20.","DOI":"10.1186\/s12886-020-01708-2"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00128071-200405030-00008","article-title":"Acanthosis nigricans associated with insulin resistance: Pathophysiology and management","volume":"5","author":"Scheen","year":"2004","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2004.06.051","article-title":"Clinical and pathologic findings of paraneoplastic dermatoses","volume":"54","author":"Chung","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jama.1909.92550170001001g","article-title":"Acanthosis nigricans: A symptom of a disorder of the abdominal sympathetic","volume":"53","author":"Pollitzer","year":"1909","journal-title":"JAMA"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/ijd.12034","article-title":"Acanthosis nigricans, tripe palms, and sign of Leser-Tr\u00e9lat in a patient with gastric adenocarcinoma: Case report and literature review in China","volume":"54","author":"Zhang","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0190-9622(00)90112-9","article-title":"Coexistence of acanthosis nigricans and the sign of Leser-Tr\u00e9lat in a patient with gastric adenocarcinoma: A case report and literature review","volume":"42","author":"Yeh","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0190-9622(88)70257-1","article-title":"Acanthosis nigricans associated with mycosis fungoides","volume":"19","author":"Schweitzer","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0714.1999.tb02039.x","article-title":"Oral manifestations as a hallmark of malignant acanthosis nigricans","volume":"28","year":"1999","journal-title":"J. Oral. Pathol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1524-4725.1980.tb01003.x","article-title":"Malignant acanthosis nigricans: A review","volume":"6","author":"Rigel","year":"1980","journal-title":"J. Dermatol. Surg. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.1991.01680070039003","article-title":"Treatment of acanthosis nigricans with tretinoin","volume":"127","author":"Darmstadt","year":"1991","journal-title":"Arch. Dermatol."},{"key":"ref_148","first-page":"33","article-title":"Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity","volume":"71","author":"Blobstein","year":"2003","journal-title":"Cutis"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/09546630802050506","article-title":"Acanthosis nigricans associated with primary hypogonadism: Successful treatment with topical calcipotriol","volume":"19","author":"Gregoriou","year":"2008","journal-title":"J. Dermatolog Treat."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/7\/1053\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:57:42Z","timestamp":1760029062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/7\/1053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":149,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cancers17071053"],"URL":"https:\/\/doi.org\/10.3390\/cancers17071053","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}